Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Interventional × icaritin × Clear all

Phase

Status

Sponsor Class

INDUSTRY 3 UNKNOWN 2 OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 1

Interventions

Cyclophosphamide 1731 Radiotherapy 1590 Cisplatin 1522 Carboplatin 1294 Gemcitabine 1202 Paclitaxel 1099 Bevacizumab 1059 Docetaxel 1043 pembrolizumab 1020 Capecitabine 979 Oxaliplatin 973 Fluorouracil 912 Dexamethasone 827 Rituximab 775 Nivolumab 771 Magnetic Resonance Spectroscopy 727 Etoposide 703 Doxorubicin 696 Radiosurgery 660 Irinotecan 659 Drug Therapy 659 Cytarabine 632 fludarabine 614 Leucovorin 575 Lenalidomide 524 fludarabine phosphate 476 Radiation 465 Temozolomide 462 Filgrastim 461 Cetuximab 456

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06893887 2025-07-02

ICT-HCC

Nanjing Tianyinshan Hospital

Phase NA Recruiting

Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡